Acquisition method (AMC)
3
FSC 6505 × ADENOSINE INJECTION
ADENOSINE INJECTION
6505-01-724-4068 FSC 6505
NSN 6505-01-724-4068 (also written 6505017244068; NIIN 01-724-4068) is an adenosine injection in Federal Supply Class 6505, Drugs and Biologicals. 5 manufacturer part numbers from 5 suppliers are on record. It was last purchased in Oct 2026.
Open for bid
No open solicitations on record for this NSN right now.
Can you win it?
This item is coded to be bought directly from the actual manufacturer (AMC 3).
Suffix (AMSC)
Z
Competition
Coded for a named source
AMC 3: buy directly from the actual manufacturer, second or later time. AMSC Z: a commercial, nondevelopmental or off-the-shelf item. The codes describe the item's status on record, not any one solicitation. What the codes mean
What it is — can you make it?
Dimensions, the FLIS specification requirements, and the manufacturer part numbers already qualified against this NSN.
Specifications
From the federal catalog (DLA FLIS / PUB LOG) — what your part has to meet. Cited specification documents can be looked up in ASSIST Quick Search ↗, DoD's public spec repository — copy the document number in.
| Requirement | Value |
|---|---|
| PRIMARY CONTAINER TYPE CQCT | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY CRLK | MILLILITERS 2.0 |
| TOTAL PRIMARY CONTAINER QUANTITY CSCW | 10 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY CXCY | ADENOSINE INTRAVENOUS SOLUTION, 2ML VIAL, 3 MG/ML, 10S |
| SECONDARY CONTAINER TYPE CQGK | VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH AKJA | MILLIGRAMS ADENOSINE PER MILLILITER 3.0 |
| FEATURES PROVIDED CBBL | STERILE |
| MEDICAL DESIGNATION AND GRADE MDES | UNITED STATES PHARMACOPEIA |
| ADMINISTRATION CSGS | INTRAVENOUS |
| SPECIAL FEATURES FEAT | INDICATED INTRAVENOUSLY FOR THE CONVERSION TO SINUS RHYTHM OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT), INCLUDING THAT ASSOCIATED WITH ACCESSORY BYPASS TRACTS (WOLFF-PARKINSON-WHITE SYNDROME). ADENOSINE INJECTION, USP DOES NOT CONVERT ATRIAL FLUTTER, ATRIAL FIBRILLATION, OR VENTRICULAR TACHYCARDIA TO NORMAL SINUS RHYTHM; FOR RAPID BOLUS INTRAVENOUS USE; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); DO NOT REFRIGERATE; CONTAINS NO PRESERVATIVES; DISCARD UNUSED PORTION; CONTAINER CLOSURE IS NOT MADE WITH NATURAL RUBBER LATEX; CONTAINS 10 VIALS, 2ML SINGLE DOSE VIAL; SUPPLIED AS A STERILE, NONPYROGENIC SOLUTION IN NORMAL SALINE. |
Manufacturer part numbers
Commercial part numbers cross-referenced to this NSN in the federal catalog — the parts that have been accepted as satisfying this stock number, and who makes them.
| Part number | CAGE | Manufacturer |
|---|---|---|
| 1674973 | 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
| 3673894 | 07TA6 | CARDINAL HEALTH 200, LLC |
| 434783 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP |
| 6505NCM249951 | 64616 | DEFENSE MEDICAL STANDARDIZATION BOARD |
| NDC63323-0651-02 | 57KZ6 | FRESENIUS KABI, LLC |
What it pays — so you can quote
The government's own price and demand record for this NSN — what past awards cleared at, so you know where to land your quote.
Latest unit price
—
Purchases
0
Total spend
—
Oct 13, 2026
Last purchased
5 · 5.0/yr
Purchase records
$427.05
Total demand
$47.45
Latest award total
Purchase history
No priced purchases on record for this NSN yet.
Related contract actions
Contract action totals, not unit prices — obligation amounts from USAspending for related awards, shown for context only. These do not appear on the price chart above.
| Action date | Award # | Recipient | Agency | Obligation |
|---|---|---|---|---|
| Sep 15, 2026 | SPE2DX25D9900/SPE2DP26F9957 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $189.80 |
| Sep 15, 2026 | SPE2DX25D9900/SPE2DP26F9955 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $47.45 |
| Sep 15, 2026 | SPE2DX25D9900/SPE2DP26F9952 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $94.90 |
| Sep 15, 2026 | SPE2DX25D9900/SPE2DP26F9951 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $47.45 |
| Oct 13, 2026 | SPE2DX25D9900/SPE2DP27F0190 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $47.45 |
Demand history
Every solicitation we've indexed for this NSN, open and closed — 2 on record. Closed RFQs (expired, cancelled, or awarded) stay here as a record of past demand; they never get removed.
Who wins this item
Does one supplier win this every time, and are the winners on the listed-source list? One dot per award.
- Award in the last 2 years
- Older award
DMS PHARMACEUTICAL GROUP INC
last award Oct 2026
AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP
no award yet
no awards on record
Listed source CARDINAL HEALTH 200, LLC
no award yet
no awards on record
Listed source DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
no award yet
no awards on record
Listed source DEFENSE MEDICAL STANDARDIZATION BOARD
no award yet
no awards on record
Listed source FRESENIUS KABI, LLC
no award yet
no awards on record
Listed source DMS PHARMACEUTICAL GROUP INC won 5 of the last 5 awards. DMS PHARMACEUTICAL GROUP INC won without being a listed source.
| Solicitation | Issued | Closes / closed | Qty | Status | |
|---|---|---|---|---|---|
| SPE2DP-26-T-4804 | Sep 1, 2026 | Sep 8, 2026 | 4 | Expired | View at DIBBS → |
| SPE2DP-26-T-4677 | Aug 18, 2026 | Aug 24, 2026 | 1 | Expired | View at DIBBS → |
Open RFQs on DIBBS → DIBBS award history ↗
About this data
- Unit prices: DLA DIBBS award records — every row links to its government record.
- AMSC: latest observed value from DIBBS solicitation history as of Oct 10, 2026.
- Contract action totals: USAspending, context only.
- Data last refreshed: 2026-10-21.
- Full methodology →
Cite this page
Citation
NSN Explorer. "ADENOSINE INJECTION." nsnexplorer.com, https://nsnexplorer.com/nsn/6505-01-724-4068/. Data as of November 7, 2026.
Link
https://nsnexplorer.com/nsn/6505-01-724-4068/